Testing differences between two types of stomach cancer using lab data
Part of Cancer, Digestive system clinical trials.
This study compares two kinds of stomach cancer (near the upper stomach/“cardia” vs non-cardia) using special lab and genetic tests (“multiomics”). It may help doctors understand differences between these cancers and improve how they are diagnosed and treated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You agree to sign the study informed consent form
- You are between 18 and 75 years old
- Your stomach cancer diagnosis was confirmed by biopsy/pathology after an endoscopy
- Your cancer may be early, advanced, or a very high-grade pre-cancer change called high-level intraepithelial neoplasia
- You have not had stomach or other gastrointestinal surgery in the past 1 year
- You have not taken certain gut-influencing medicines or supplements in the last month, and you have no ongoing digestive conditions that could interfere with results
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of getting stomach cancer tissue: a camera-guided biopsy and a tissue sample taken during planned stomach surgery. The goal is to see which sample better supports molecular (gene-based) testing to guide diagnosis.
This trial looks at tiny pieces of DNA found outside cells in stomach tissue to better understand how gastric (stomach) cancer starts and progresses. It may help future patients by improving how doctors study stomach cancer from biopsy and surgical samples.
This study is looking for people with stomach discomfort who are coming to this hospital for an endoscopy. Researchers will use the test results to help catch stomach cancer early and keep an eye on it after surgery.
This study looks at stomach (or stomach–esophagus junction) cancer tissue, treatment details, and patient-reported experiences to better predict how you may respond to standard chemotherapy. It may help personalize future treatment by identifying markers that connect your tumor environment and your expected outcomes.
This study looks for metabolic markers in your blood and tumor tissue to help find stomach cancer early, predict your prognosis, and watch for recurrence. If you qualify, you would give blood and tumor samples for testing.
This study is testing whether small molecules in your blood (called 'small non-coding RNAs') can help doctors more accurately diagnose stomach cancer. If you have recently been diagnosed, this study will look for those molecules to see if they can be used as a simple blood test in the future.
Hear when a new Stomach Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.